Frontlight ResearchEarly access
Trial site
Elblandkliniken Stiftung & Co.KG
- 5running trials
- 3closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia3 trials
- Colorectal cancer3 trials
- Pancreatic cancer2 trials
- Chronic kidney disease1 trial
- Myelodysplastic syndromes1 trial
- Phase
- Phase 36 trials
- Phase 22 trials
- Status
- Completed3 trials
- Recruiting3 trials
- Active, not recruiting2 trials
- Suspended1 trial
- Lead sponsor
- Arcus Biosciences, Inc.1 trial
- AstraZeneca1 trial
- DKMS gemeinnützige GmbH1 trial
- Federation Francophone de Cancerologie Digestive1 trial
- Heidelberg University1 trial
- and 4 more
Running trials
Recruiting
Recruiting
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Active, not recruiting
Active, not recruiting
Recruiting
Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Chronic kidney disease1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026